Hemispherian Gets FDA IND Clearance for Glioblastoma Drug GLIX1
06 Aug 2025 //
PR NEWSWIRE
Hemispherian Gets FDA Orphan Drug Status for GLIX1
01 Jul 2025 //
PR NEWSWIRE
Hemispherian gets positive opinion for GLIX1 in glioma EU
06 Jun 2025 //
PR NEWSWIRE
Hemispherian raises tranche of a Series A to fund novel cancer therapeutics
24 Nov 2022 //
PRNEWSWIRE